7 research outputs found
Internal Medicine Residents and the Fundus: Improving Skill With Direct Ophthalmoscopes and Increasing Knowledge of Basic Ocular Pathology
Get PDFA Case of Erythema Elevatum DiutinumAssociated with IgA Monoclonal Gammopathy and Multiple Myeloma
Get PDF
Lymphoma Masquerading as Pneumonia with Acute Renal Failure: A rare clinical and radiological presentation of diffuse large B cell gastric lymphoma (DLBCL)
Get PDF
Tocilizumab Treatment in COVID-19 Patients: Comparing Cutaneous Disease and Adverse Drug Effects.
No full textActemra (tocilizumab) received emergency use authorization for the treatment of coronavirus disease 2019 (COVID-19) in June 2021. Literature has linked numerous cutaneous adverse effects to tocilizumab. In this current survey, investigators reviewed and compared these adverse effects to the common cutaneous manifestations of COVID-19. While similarities in patient presentation exist, important distinctions are made to aid dermatologists in their clinical diagnosis. J Drugs Dermatol. 2023;22(12):e42-e43. doi:10.36849/JDD.6532e
